PubMed · 12938574
[Clopidogrel and thrombopenia. A case report].
Abstract
We report our experience with a case of isolated profound thrombocytopenia after clopidogrel (thienopyridine) administration. No adverse event such as bleeding or thrombotic event had occurred, although clopidogrel has been discontinued two weeks after the coronary artery stenting. Despite the safety of clopidogrel, this case demonstrates that clopidogrel can be associated not only with thrombotic thrombocytopenic purpura but also with isolated thrombocytopenia.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G Helft, I Elalamy, C Laudy, D Tran, F Beygui, C Le Feuvre, F Ounissi, B Monnet de Lorbeau, C Khellaf, J P Metzger. 2003. [Clopidogrel and thrombopenia. A case report].. https://doi.org/10.1016/s0003-3928(02)00185-3
Cite the original work for its findings. Save a collection to share your selection of sources.